New developments in insulin delivery

Drug Development and Industrial Pharmacy

Volumn 29, Issue 3, 2003, Pages 253-265

  Khan Ghilzai, Naushad M ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Delivery; Different routes; Insulin; Patents

Indexed keywords

'M2'; AI 40; AI 401; BIOPOLYMER; CYANOACRYLATE DERIVATIVE; ENDOREX; EUDRAGIT; INSULIN; MACRULIN; MICROSPHERE; POLIDOCANOL; POLY(CYANOACRYLATE); POLYACRYLIC ACID; POLYOXYETHYLENE STEARYL ETHER; POLYSACCHARIDE; SALICYLATE SODIUM; UNCLASSIFIED DRUG;

CELL ENCAPSULATION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTROPORATION; ENCAPSULATION; GASTROINTESTINAL ABSORPTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; IONTOPHORESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PATENT; RECOMBINANT DNA TECHNOLOGY; REVIEW;

DIABETES MELLITUS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; TECHNOLOGY, PHARMACEUTICAL;

EID: 0038641805     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120018199     Document Type: Review

References (98)

1. Banting, F.G.; Best, C.H. J. Lab. Clin. Med. 1922, 7, 464.
2. Peskind, S; Ragoff, J.M.; Stewart, G.N. Am. J. Physiol. 1924, 68, 530.
3. Brange, J.; Ribel, U.; Hansen, J.F.; Dodson, G.; Hansen, M.T.; Havelund, S.; Melborg, S.G.; Norris, F.; Snel, L.; Sorensen, A.R.; Voigt, H.O. Nature 1988, 333, 679.
4. Gibaldi, M. AAPS News September issue, 1999. Source: Scrip, July 16, 1999.
5. Source: AAMI Annual Meeting in Boston, June 6, 1999. Fighting Diabetes; UD researchers move closer to chip-based control of 'smart', implantable insulin pump. http://fourier.che. udel.edu/news/eurekalert-release.html (accessed June 2002).
6. Schichin, M.; Karasak, K.; Etani, N.; Okada, A.; Skigeta, Y. Endocrin. Jpn. 1972, 19, 309.
7. Ziv, E.; Lior, O.; Kidron, M. Biochem. Pharmacol. 1987, 36, 1035.
8. Schichiri, M.; Etani, N.; Okada, A. Diabetes 1973, 22, 459.
9. Schichiri, M.; Okada, A.; Kawamon, R.; Etani, N.; Shimizu, Y. Endocrinology 1973, 93, 1371.
10. Balsam, M.J.; Holtzapple, P.G.; Kaye, R.; Sewell, E.M. Pedriatr. J. 1971, 79, 1011.
11. Crane, C.W.; Luntz, G.R.W.N. Diabetes 1968, 12, 625.
12. Mesiha, M.S. APhA Annual Meeting 142 (Abstr.), 158, (1995).
13. Mesiha, M.; Plakogiannis, F.; Vejosoth, S. Int. J. Pharm. 1994, 111, 213.
14. Hosny, E.H.; Khan Ghilzai, N.M; Elmazar, M.M. Pharm. Acta Helvetiae 1997, 72, 203.
15. Yamamoto, A.; Taniguchi, T.; Rikyuu, K.; Tsuji, T.; Fujita, T.; Murakami, M.; Muranishet, S. Pharm. Res. 1994, 11, 1496.
16. Morishita, M.; Morishita, I.; Takayama, K.; Machida, Y.; Nagai, T. Int. J. Pharm. 1992, 78, 1.
17. Tozaki, M.; Komoike, J.; Tada, C.; Mariyama, T.; Terabe, A.; Suzuki, T.; Yamamoto, A.; Muranishi, S. J. Pharm. Sci. 1997, 86, 1016.
18. Saffran, M.; Kumar, G.S. Science 1986, 233, 1081.
19. Morishita, M.; Morishita, I.; Takayama, K.; Machida, Y.; Nagaiet, I. Biol. Pharm. Bull. 1993, 16, 68.
20. Hosny, E.A.; Khan Ghilzai, N.M.; Al-Dhawalie, A.H. Drug Dev. Ind. Pharm. 1995, 21, 1583.
21. Stefanov, A.V.; Komonenko, N.I.; Lishko, V.K.; Shevchenko, A.V. Ukr. Biokhim. Zn. 1980, 52, 497.
22. Fasano, A.; Uzzan, S.J. Clin. Invest. 1997, 99, 1158.
23. Damage, C.; Michel, C.; Aprahamian, A.; Couvreur, P.; Devissaguetet, J.P. J. Controlled Release 1990, 13, 233.
24. www.nobexcorp.com/news/1999/0215.html (accessed May 2001).
25. Emisphere Technologies. www.emisphere.com/news/home.html (accessed June 2002).
26. www.hadassah.org.il/news/OralInsulinDov0701.htm (accessed Jan 2002).
27. AutoImmune. www.autoimmuneinc.com (accessed June 2002).
28. New delivery System for insulin due soon, www.ims-lobal.com/insight/news_story/news_ story_991001a.htm (accessed June 2001).
29. Ariad Pharmaceuticals www.pharmacology. ab...ary/0daily/00news/blnews000203a.htm (accessed June 2001).
30. iMEDD website http://11192.148.24631/imeddpaper.html (accessed June 2001).
31. Oral delivery of insulin www.bgu.ac.il/bgn/ oralin.html (accessed June 2001).
32. www.pharmalicensing.com/news/adisp/991348909_3b16c8ada4550 (accessed August 2001).
33. Christie, C.D.; Hanzel, R.F. J. Clin. Invest. 1931, 10, 787.
34. Chiou, G.C.Y.; Shen, Z.F.; Zheng, Y.Q. J. Ocular Pharmacol. 1990, 6, 233.
35. Chiou, G.C.Y.; Li, B.H.P. J. Ocular Pharmacol. 1993, 9, 85.
36. Chiou, G.C.Y.; Chuang, C.Y. J. Pharm. Sci. 1989, 78, 815.
37. Pillion, D.J.; Atchison, J.A.; Stollt, J.; McCracken, D.; Gargiulo, C.; Meezan, E. J. Ocular Pharmacol. 1994, 10, 461.
38. Lee, Y.C.; Simamora, P.; Yalkowsky, S.H. J. Pharm. Sci. 1997, 86, 430.
39. Lee, Y.C.; Yalkowsky, S.H.; Int. J. Pharm. Sci. 1999, 185 (2), 199.
40. An Overview of Insulin Delivery, Where we are headed in..the future...? www.diabetesinterview.com/archive/Jan01?jan201.shtml (accessed Feb 2002).
41. www.ne-optometry.edu/faculty/faculty/koevary.html (accessed June 2001).
42. www.biosantepharma.com (accessed June 2001).
43. Lurbe, B.L.; Georgopoulos, A.; Adams, III, G.K. JAMA 1993, 269, 2109.
44. Kawashima, Y.; Yamamoto, H.; Takeuchi, H.; Fujioka, S.; Hino, T.J. Controlled Release 1999, 62, 279.
45. www.journal.diabetes.org/FullText/ClinicalDia betes/V19N101/pg13htm (accessed May 2001).
46. Epic Therapeutics Website www.epictherapeutics. com/news.htm (accessed June 2001).
47. Spiros® Pulmonary Drug delivery System, www.durapharm.com(accessed June 2001).
48. www.Pharmabiz.com/archives/sept2001/clitri359.asp (accessed Nov 2001).
49. www.imarx.com/pulmorx.asp (accessed Jan 2002).
50. www.generex.com/section5/strategy.html (accessed May 2001).
51. Diabetes Research: Insulin without needles. www. txtell.utexas.edu/stories/d004-full.html (accessed May 2001).
52. White, J.R.; Campbell, R.K.; Hirsch, I.B. Postgrad. Med. 1997, 101, 58-70.
53. O'Hagan, D.T.; Illum, L. Crit. Rev. Ther. Drug Carrier Syst. 1990, 7, 35.
54. www.bentleypharm.com (accessed Jan 2002).
55. Vectura and ML Laboratories collaborate to develop inhaled biotech products www.vectura. co.uk/corporate/press/ml_lab_14_09-2000.htm (accessed Jan 2002).
56. www.westpharma.com/nasal.htm (accessed Feb 2002).
57. Company formed to exploit aerosol drugs market. www.businessweekly.co.uk/news/view_article.asp?article_id=5134 (accessed Feb. 202002).
58. Touitou, E.; Donbrow, M.; Azaz, E. J. Pharm. Pharmacol. 1978, 30, 662.
59. Hosny, E.A.; El-Ahmady, O.; El-Shattawy, H.; Nabih, A.; El-Kabbany, Arzneim-Forsch. 1994, 44, 611.
60. Richardson, J.L.; Farraj, N.F.; Illum, L. Int. J. Pharm. 1992, 88, 319.
61. Golomb, G.; Avranoff, A.; Hoffman, A. Pharm. Res. 1993, 10, 828.
62. August, B.J. Int. J. Pharm. 1994, 105, 210.
63. Nagai, T.; Machida, Y. Pharm. Int. 1985, 6, 196.
64. August, B.J.; Rogers, N.J. Pharm. Res. 1998, 5, 305.
65. Valentis and Flemington to develop insulin spray. www.pharmalicensing.com/news/adisp/ 966805972_39a049d46b943 (accessed Jan 2002).
66. www.plasticsurgeon4u.com/developm.htm (accessed Jan 2002).
67. Chien, Y.M.; Lelawonga, P.; Siddiqui, O.; Sun, Y.; Shi, W.H. J. Controlled Release. 1990, 13, 263.
68. Mitragotri, S.; Blankschtein, D.; Langer, R. Science 1995, 269, 850.
69. Cygnus Pharmaceutical, www.clinmark.com/ dermal-delivery.html (accessed May 2001).
70. www.encsys.com/ustrip.html (accessed Jan 2002).
71. Dr. Sen. www.roswellpark.org/research/mcbp/ newpage16.htm (accessed June 2001).
72. www.alteatech.com (accessed June 2001).
73. Transdermal insulin delivery www.bgu.ac.il/ bgn/Insulin.html (accessed June 2001).
74. Scrip, World Pharmaceutical News, October 15th 1999, Issue No. 2481.
75. Vector Medical Technologies, Inc., www.vector medtech.com/pree6htm (accessed June 2001).
76. Noven Pharmaceuticals, www.nfb.org/vod/ vow0007.htm (accessed June 2001).
77. www.imrax.com/sonoderm.asp (accessed Jan 2002).
78. www.sontra.com/new/application.html (accessed Feb 2002).
79. Titus, T.; Badet L.; Gray D.W.R. Expert review in Molecular Medicine: www.ermm.cbcu.cam. ac.uk (accessed May 2001).
80. Shapiro, A.M.J.; Lakey, J.R.T.; Ryan, E.A.; Korbutt, G.S.; Toth, E.; Warnock, G.L.; Kneteman, N.M.; Rajotte, R.V. N. Engl. J. Med. 2002, 343, 230-238.
81. www.dukenews.duke.edu/Med/baboon.htm (accessed Jan 2002).
82. Desai, T.; Leoni, L. IEEE Trans. Biomed. Eng. 2001, 48 (11), 1335-1341.
83. www.dringet.org/html/encapsulation.htm (accessed Jan 2002).
84. www.pharmactives.com/readnews.cfm?ref= 16 (accessed Feb 2002).
85. Aradigam Corporation New Release www. corporate-ir.net/ireye (accessed May 2001).
86. www.delphion.com/details?pn=US05672581 (accessed Nov 2001).
87. www.delphion.com/details?pn=US05970973 (accessed Nov 2001).
88. www.delphion.com/details?pn=US05941240 (accessed Nov 2001).
89. www.delphion.com/details?pn=US06167880 (accessed Nov 2001).
90. www.delphion.com/details?pn=US06085753 (accessed Nov 2001).
91. www.delphion.com/details?pn=US05915378 (accessed Nov 2001).
92. Helix BioPharma granted drug delivery patent, www.pharmalicensing.com.news/adisp (accessed Jan 2002).
93. www.delphion.com/details?pn=US06165225 (accessed Jan 2002).
94. Dura Pharmaceuticals Issued Patent for methods of drug powder inhalation www.shareholder. com/dura/news (accessed May 2001).
95. Generex receives patent for delivery System www. thebullandbear.com/bb-reporter/bbfrarchive/ generex.htm (accessed Jan 2002).
96. Waratah Pharmaceuticals receives US patent extending its Islet Neogenesis Technology www.waratah.com (accessed Jan 2002).
97. Islet Technology acquires remaining co-owned rights www.pharmalicensing.com/news/adisp/ 1001456704_3bb1044oeb4ba (accessed Jan 2002).
98. www.autoimmune.com/R_and_D/pubs.html (accessed June 2002).